SI-BONE Files for Proposed IPO

SI-BONE publicly filed a registration statement for a proposed US $97.7MM initial public offering of shares of its common stock, and applied to list on NASDAQ as SIBN. Proceeds will primarily support commercialization activities.

The company markets iFuse and iFuse-3D minimally invasive surgical implant systems for the treatment of sacroiliac...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us